The ingredients commonly used in GLP-1 support have been researched primarily through oral intake, making oral supplements a more evidence-based choice (7,9,10,11,12)
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nature Chemical Biology , 5(10), 749757
The study used a reverse translational approach, starting with observations from human use and testing specific mechanisms in controlled animal experiments
Practice-Changing Education Experience education that goes beyond theory
What I found interesting in that data was how consistent the early appetite response was across dose groups
Between high costs, insurance limitations, and potential side effects, these medications may not be the right fit for many